Paper36770674
Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates.
Denner TC and 5 others. Molecules, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates. Papers, record 36770674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triterpenes | Major topic |
| Oleanolic Acid | Major topic |
| Glycyrrhetinic Acid | Major topic |
| Humans | |
| Acetazolamide | |
| Molecular Structure | |
| Structure-Activity Relationship | |
| Carbonic Anhydrase II | |
| Cell Line, Tumor | |
| Carbonic Anhydrase Inhibitors | |
| Betulinic Acid |
Source PubMed
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33121862 | Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33121862 | PubMed |
| 2 | 33345714 | Computer-aided identification of human carbonic anhydrase isoenzyme VII inhibitors as potential antiepileptic agents. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/33345714 | PubMed |
| 3 | 35328549 | Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328549 | PubMed |
| 4 | 33155700 | Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors. | Arch Pharm (Weinheim) | 2021 | https://conductscience.org/library/papers/33155700 | PubMed |
| 5 | 30925064 | Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma. | J Med Chem | 2019 | https://conductscience.org/library/papers/30925064 | PubMed |
| 6 | 36149291 | Arabidopsis plastid carbonic anhydrase βCA5 is important for normal plant growth. | Plant Physiol | 2022 | https://conductscience.org/library/papers/36149291 | PubMed |
| 7 | 33773285 | Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33773285 | PubMed |
| 8 | 34948200 | Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948200 | PubMed |
| 9 | 21899058 | [Synthesis and antitumor activity of betulin, erythrodiol and uvaol aminopropoxy derivatives]. | Bioorg Khim | 2011 | https://conductscience.org/library/papers/21899058 | PubMed |
| 10 | 19914836 | Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases. | Bioorg Med Chem | 2010 | https://conductscience.org/library/papers/19914836 | PubMed |
| 11 | 34068564 | Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34068564 | PubMed |
| 12 | 29809145 | A surface proton antenna in carbonic anhydrase II supports lactate transport in cancer cells. | Elife | 2018 | https://conductscience.org/library/papers/29809145 | PubMed |
| 13 | 31847904 | Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment. | Cell Commun Signal | 2019 | https://conductscience.org/library/papers/31847904 | PubMed |
| 14 | 31262047 | Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31262047 | PubMed |
| 15 | 23074198 | Function of carbonic anhydrase IX in glioblastoma multiforme. | Neuro Oncol | 2012 | https://conductscience.org/library/papers/23074198 | PubMed |
| 16 | 32478924 | Management of glioblastoma: State of the art and future directions. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32478924 | PubMed |
| 17 | 20100662 | 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches. | Bioorg Med Chem | 2010 | https://conductscience.org/library/papers/20100662 | PubMed |
| 18 | 17614290 | Synthesis and structure-activity relationship study of cytotoxic germanicane- and lupane-type 3beta-O-monodesmosidic saponins starting from betulin. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17614290 | PubMed |
| 19 | 36431918 | Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? | Molecules | 2022 | https://conductscience.org/library/papers/36431918 | PubMed |
| 20 | 35458743 | Carbonic Anhydrase Activators for Neurodegeneration: An Overview. | Molecules | 2022 | https://conductscience.org/library/papers/35458743 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41694696 | Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl-Substituted Halogenated and Methoxy Conduritols. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/41694696 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CA12 | 771 | PubTator's text mining | https://conductscience.org/library/genes/771 | NCBI Gene |
| CA2 | 760 | PubTator's text mining | https://conductscience.org/library/genes/760 | NCBI Gene |
| CA9 | 768 | PubTator's text mining | https://conductscience.org/library/genes/768 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770674
GET https://conductscience.org/api/papers/v1/36770674/references?page=2